Disease Landscape and Forecast 인사이트
종합적인 시장 정보와 실행 가능한 인사이트를 통해 장기적인 질병 전략을 최적화하세요.
Report
2023년 6월 13일
Renal Cell Carcinoma – Current Treatment – Current Treatment: Physician Insights – Renal Cell Carcinoma (US)
The addition of immune checkpoint inhibitors to the renal cell carcinoma armamentarium has significantly changed the treatment of this disease. In 2021, Keytruda (Merck & Co.) became the first…
Report
2023년 6월 8일
Renal Cell Carcinoma – Current Treatment – Treatment Sequencing – Renal Cell Carcinoma (US)
Key benefits and usesPinpoint current drug positioning and uptake in one snapshot to facilitate forecasting.Drill down into physicians’ treatment sequences and understand who to position against…
